Mensinger Mike

CIK 00020485001 companyIRVINE, CA

SEC Profile

Transactions

Companies

Filings

CIK

0002048500

Recent Transactions

25 trades

Sale
Beta Bionics, Inc.$BBNX
Common Stock
2026-06-02$12.61/sh−4,378→ 184,415 total
Sale
Beta Bionics, Inc.$BBNX
Common Stock
2026-03-02$12.36/sh−1,064→ 188,793 total
Award
Beta Bionics, Inc.$BBNX
Employee Stock Option (right to buy)
2026-02-27+91,520→ 91,520 total
Award
Beta Bionics, Inc.$BBNX
Employee Stock Option (right to buy)
2026-02-27+58,749→ 58,749 total
Award
Beta Bionics, Inc.$BBNX
Common Stock
2026-02-27+109,105→ 189,857 total
Sale
Beta Bionics, Inc.$BBNX
Common Stock
2026-01-06$30.10/sh−2,200→ 80,752 total
Sale
Beta Bionics, Inc.$BBNX
Common Stock
2026-01-02$30.20/sh−600→ 82,952 total
Sale
Beta Bionics, Inc.$BBNX
Common Stock
2026-01-02$29.56/sh−7,200→ 83,552 total
Sale
Beta Bionics, Inc.$BBNX
Common Stock
2025-12-02$29.34/sh−1,063→ 90,752 total
Sale
Beta Bionics, Inc.$BBNX
Common Stock
2025-09-02$18.86/sh−1,089→ 91,815 total
Sale
Beta Bionics, Inc.$BBNX
Common Stock
2025-06-02$17.03/sh−306→ 93,713 total
Sale
Beta Bionics, Inc.$BBNX
Common Stock
2025-06-02$18.15/sh−708→ 93,005 total
Sale
Beta Bionics, Inc.$BBNX
Common Stock
2025-06-02$18.69/sh−101→ 92,904 total
Award
Beta Bionics, Inc.$BBNX
Employee Stock Option (right to buy)
2025-02-27+52,000→ 52,000 total
Award
Beta Bionics, Inc.$BBNX
Common Stock
2025-02-27+35,000→ 94,019 total
Conversion
Beta Bionics, Inc.$BBNX
Common Stock
2025-01-31+15,107→ 15,107 total
Conversion
Beta Bionics, Inc.$BBNX
Class B Common Stock Warrant (right to buy)
2025-01-31+10,575→ 10,575 total
Purchase
Beta Bionics, Inc.$BBNX
Common Stock
2025-01-31$17.00/sh+33,350→ 59,019 total
Sale
Beta Bionics, Inc.$BBNX
Common Stock
2025-01-31$17.00/sh−13→ 25,669 total
Award
Beta Bionics, Inc.$BBNX
Employee Stock Option (right to buy)
2025-01-31+236,553→ 236,553 total
Exercise of In-Money
Beta Bionics, Inc.$BBNX
Common Stock
2025-01-31$0.02/sh+10,575→ 25,682 total
Exercise of In-Money
Beta Bionics, Inc.$BBNX
Class B Common Stock Warrant (right to buy)
2025-01-31−10,575→ 0 total
Award
Beta Bionics, Inc.$BBNX
Employee Stock Option (right to buy)
2025-01-31+110,278→ 110,278 total
Conversion
Beta Bionics, Inc.$BBNX
Series D Preferred Stock
2025-01-31−15,107→ 0 total
Award
Beta Bionics, Inc.$BBNX
Employee Stock Option (right to buy)
2025-01-29+110,278→ 110,278 total

Companies

Beta Bionics, Inc.
Chief Product Officer
$BBNX

Recent Filings

Address

C/O BETA BIONICS, INC. 11 HUGHES

IRVINE, CA, 92618

View on SEC.gov